GPT and metabolic dysfunction-associated steatotic liver disease: Patients with NAFLD had significantly higher fasting glucose, HOMA-IR, HbA1c, AST, ALT, triglycerides, CRP, and lymphocyte count than healthy controls (all p < 0.05).